{"disease":{"id":"malaria-vaccines","name":"malaria vaccines"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03855995","title":"A Study Assessing the Safety, Efficacy, and Impact of GlaxoSmithKline Biologicals' RTS, S/AS01E Malaria Vaccine in Young Children Across Sub-Saharan Africa","phase":"","overall_status":"COMPLETED","enrollment_count":77953,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT02251704","title":"Epidemiology Study of Malaria Transmission Intensity in Sub-Saharan Africa","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":54115,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01190202","title":"Epidemiology Study of Malaria Transmission Intensity in Africa","phase":"NA","overall_status":"COMPLETED","enrollment_count":21618,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06879327","title":"Infant Malaria Vaccine Schedule Optimization","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"PATH","has_results":false},{"nct_id":"NCT01345240","title":"Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":705,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02699099","title":"Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":699,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00289185","title":"Study of Safety, Immunogenicity and Efficacy of a Candidate Malaria Vaccine in Tanzanian Infants","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":340,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00340431","title":"Experimental Vaccine for Plasmodium Falciparum Malaria","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":0,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00977899","title":"Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate Vaccine","phase":"PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}